Amphastar Pharmaceuticals (AMPH) Research & Development (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly Research & Development of $26.7 million for Q1 2026, up 125.32% year-over-year from $11.9 million in Q1 2025, and up 160.11% quarter-over-quarter from $10.3 million in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Research & Development (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Research & Development history runs 14 years deep, the most recent figure standing at $26.7 million for Q1 2026.
- In Q1 2026, Research & Development rose 125.32% year-over-year to $26.7 million; the TTM figure through Mar 2026 stood at $68.6 million (up 30.97% YoY), while the FY2025 annual figure was $43.9 million, up 16.09% from the prior year.
- Research & Development for Q1 2026 stood at $26.7 million, up from $10.3 million in the prior quarter.
- The five-year high for Research & Development was $26.7 million in Q1 2026, with the low at $4.8 million in Q3 2022.
- The 5-year median for Research & Development is $11.9 million (2025), against an average of $13.7 million.
- The sharpest annual moves came in 2022 and 2023: Research & Development tumbled 63.73% in 2022, then jumped 259.03% in 2023.
- Amphastar Pharmaceuticals' Research & Development stood at $17.2 million in 2022, then sank by 49.99% to $8.6 million in 2023, then climbed by 20.94% to $10.4 million in 2024, then dropped by 1.39% to $10.3 million in 2025, then jumped by 160.11% to $26.7 million in 2026.
- Business Quant data shows AMPH's Research & Development at $26.7 million in Q1 2026, $10.3 million in Q4 2025, and $11.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 970.00 Mn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -1.05 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 146.30 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 248.30 Mn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 326.70 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 92.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 934.42 Mn | 644.30 Mn | 93.47 Mn | 22.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22.16 Mn |
| Mar 31, 2026 | 26.74 Mn |
| Dec 31, 2025 | 10.28 Mn |
| Sep 30, 2025 | 11.51 Mn |
| Jun 30, 2025 | 20.08 Mn |
| Mar 31, 2025 | 11.87 Mn |
| Dec 31, 2024 | 10.42 Mn |
| Sep 30, 2024 | 21.08 Mn |
| Jun 30, 2024 | 9.01 Mn |
| Mar 31, 2024 | 17.04 Mn |
| Dec 31, 2023 | 8.62 Mn |
| Sep 30, 2023 | 16.66 Mn |
| Jun 30, 2023 | 16.84 Mn |
| Mar 31, 2023 | 19.82 Mn |
| Dec 31, 2022 | 17.24 Mn |
| Sep 30, 2022 | 4.78 Mn |
| Jun 30, 2022 | 5.76 Mn |
| Mar 31, 2022 | 5.52 Mn |
| Dec 31, 2021 | 47.52 Mn |
| Sep 30, 2021 | 4.75 Mn |